GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (FRA:CHY) » Definitions » EPS (Basic)

ChemoMetec AS (FRA:CHY) EPS (Basic) : €1.30 (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is ChemoMetec AS EPS (Basic)?

ChemoMetec AS's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was €0.80. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was €1.30.

ChemoMetec AS's EPS (Diluted) for the six months ended in Dec. 2024 was €0.80. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was €1.30.

ChemoMetec AS's EPS without NRI for the six months ended in Dec. 2024 was €0.80. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 1.30.

During the past 12 months, ChemoMetec AS's average EPS without NRIGrowth Rate was 17.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 15.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 29.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 56.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, ChemoMetec AS's highest 3-Year average EPS without NRI Growth Rate was 223.80% per year. The lowest was -89.90% per year. And the median was 54.35% per year.

ChemoMetec AS EPS (Basic) Historical Data

The historical data trend for ChemoMetec AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS EPS (Basic) Chart

ChemoMetec AS Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.68 1.23 1.38 1.05

ChemoMetec AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.57 0.54 0.51 0.80

ChemoMetec AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

ChemoMetec AS's Basic EPS for the fiscal year that ended in Jun. 2024 is calculated as

Basic EPS (A: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(18.26-0)/17.402
=1.05

ChemoMetec AS's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(13.859-0)/17.399
=0.80

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChemoMetec AS  (FRA:CHY) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ChemoMetec AS EPS (Basic) Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

ChemoMetec AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (FRA:CHY) » Definitions » EPS (Basic)
Comparable Companies
OCSE:EMBLA OCSE:GN OCSE:SMSMED OCSE:VIRO OCSE:AMBU B ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH STE PODD XSWX:SOON TSE:7733 SHSE:688271
Traded in Other Exchanges
CHEMMc:UK 0DZ0:UK CHEMM:Denmark CHY:Germany
Address
Gydevang 43, Allerod, DNK, 3450
Website
https://www.chemometec.com
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.